In business to treat cancer.
D035843:Biomedical Research; D004274:DNA, Recombinant; D004467:Economics; D005069:Evaluation Studies as Topic; D035082:Federal Government; D005378:Financial Support; D006076:Government; D033161:Government Regulation; D015276:Health Care Rationing; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D008722:Methods; D009369:Neoplasms; D005791:Patient Care; D018579:Patient Selection; D010361:Patients; D004364:Pharmaceutical Preparations; D010820:Physicians; D012106:Research; D012108:Research Personnel; D035842:Research Subjects; D012926:Social Control, Formal; D012959:Socioeconomic Factors; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration
Biomedical and Behavioral Research; Biotherapeutics Inc.; National Cancer Institute; Popular Approach/Source; Trade Secrets